Behavior Modification Maintenance with Long-Term Blood Glucose and Weight Management in Prader-Willi Syndrome Complicated with Diabetes: Team Management Approach Combined with Pharmacological Treatment

Case Reports in Medicine
Eri KatoMasafumi Fukagawa

Abstract

The patient was a 40-year-old woman, who had been diagnosed with Prader-Willi syndrome (PWS) at 1 year of age and type 2 diabetes at 27 years of age. At 34 years of age, she was hospitalized to start insulin therapy and receive guidance on treatment. During the next 6 months and through regular once-monthly outpatient clinic visits, the blood glucose level was relatively stabilized although body weight gradually increased. Two years following discharge, the blood glucose level became unstable, and she was hospitalized again to receive guidance on treatment. A team medicine-based approach was established upon hospitalization. The basic treatment was unchanged (insulin, diet, and exercise). The approach taken by the team included understanding the characteristics of PWS by all team members, clear definition of treatment goals, positive evaluation of the patient, and maintenance of the patient's motivation for treatment. Anxiety and stress related to mother's illness dampened motivation and adherence to treatment, but the addition of appropriate pharmacological treatment helped in rapid recovery of motivation to adhere to the treatment protocol. At 3 years after discharge, HbA1c is maintained at around 6%, and body weight continue...Continue Reading

References

Oct 1, 1976·American Journal of Diseases of Children·V A Holm, P L Pipes
Sep 1, 1992·The American Psychologist·J O ProchaskaJ C Norcross
Jan 1, 1989·Journal of the Royal Society of Medicine·D J ClarkeJ A CORBETT
Oct 1, 1995·Journal of Intellectual Disability Research : JIDR·A J HollandJ Dallow
Aug 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·J GilmourM Pembrey
Jan 10, 2003·The Journal of Pediatrics·Urs EiholzerKatrin Kromeyer-Hauschild
Nov 9, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·E C HintonA M Owen
Sep 14, 2007·Scandinavian Journal of Public Health·Rob H Van HoorenGuy A M Widdershoven
Jul 30, 2010·Research in Developmental Disabilities·Luca VismaraPaolo Capodaglio
Jan 14, 2011·Diabetes Research and Clinical Practice·Ian W SeethoDevaka J S Fernando
Aug 23, 2011·Journal of Neurodevelopmental Disorders·Elisabeth M DykensElizabeth Roof
Apr 2, 2013·The Journal of Clinical Endocrinology and Metabolism·Cheri L DealUNKNOWN 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants
Apr 1, 2011·Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology·Takayoshi TsuchiyaToshiro Nagai
Jun 13, 2015·Journal of Endocrinological Investigation·M A AnguloM E Cataletto
May 5, 2016·The British Journal of Educational Psychology·Claire WilsonMark A Elliott
Mar 8, 2017·Journal of Intellectual Disability Research : JIDR·E L Haig, K A Woodcock
Oct 17, 2018·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Antonino CrinòGraziano Grugni
Dec 7, 2018·International Journal of Retina and Vitreous·Mohamed A HamidBaruch D Kuppermann

❮ Previous
Next ❯

Citations

Feb 8, 2020·Current Diabetes Reports·Antonino Crinò, Graziano Grugni
Apr 24, 2021·Journal of Endocrinological Investigation·G MuscogiuriUNKNOWN RESTARE

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

The Journal of Pediatrics
V A Holm, P L Pipes
Journal of Intellectual & Developmental Disability
Josette WulffaertIna A Van Berckelaer-Onnes
© 2021 Meta ULC. All rights reserved